← Back to Analyst Consensus 
RYTM Buy
RHYTHM PHARMACEUTICALS, INC.
Current Price —
Implied Upside —
Analysts 24
30-Day Momentum
▲ 1 upgrades / ▼ 0 downgrades / 3 reiterations from 4 firms
Next Earnings
Nov 3, 2026 (8 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 16, 2026 | William Blair | initiate | — → Outperform | — | 48% |
| Oct 15, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 54% |
| Oct 12, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Oct 8, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Aug 28, 2026 | Deutsche Bank | initiate | — → Hold | — | 57% |
| Aug 7, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 54% |
| Aug 5, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Aug 5, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Aug 5, 2026 | Citizens | maintain | Market Outperform → Market Outperform | — | 46% |
| Jul 27, 2026 | JP Morgan | initiate | — → Overweight | — | 54% |
| Jul 7, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Jun 16, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Jun 15, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| May 7, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| May 6, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| May 6, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| Mar 23, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Mar 20, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Mar 20, 2026 | B of A Securities | maintain | Buy → Buy | — | 53% |
| Mar 20, 2026 | Citizens | maintain | Market Outperform → Market Outperform | — | 46% |
| Mar 18, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Mar 18, 2026 | HC Wainwright& Co. | maintain | Buy → Buy | — | — |
| Mar 17, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Mar 17, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Mar 17, 2026 | Citizens | maintain | Market Outperform → Market Outperform | — | 46% |
| Mar 17, 2026 | B of A Securities | maintain | Buy → Buy | — | 53% |
| Mar 17, 2026 | Morgan Stanley | maintain | Overweight → Overweight | — | 54% |
| Mar 17, 2026 | Needham | maintain | Buy → Buy | — | 50% |
| Mar 12, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| Mar 2, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Mar 2, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Feb 27, 2026 | Wells Fargo | maintain | Overweight → Overweight | $136 | 54% |
| Feb 27, 2026 | Citizens | maintain | Market Outperform → Market Outperform | $176 | 46% |
| Feb 27, 2026 | Guggenheim | maintain | Buy → Buy | $143 | 52% |
| Feb 26, 2026 | Needham | maintain | Buy → Buy | $139 | 50% |
| Feb 19, 2026 | RBC Capital | initiate | — → Outperform | $145 | 55% |
| Jan 20, 2026 | Wells Fargo | maintain | Overweight → Overweight | $145 | 54% |
| Jan 20, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | $125 | 44% |
| Jan 9, 2026 | Needham | maintain | Buy → Buy | $148 | 50% |
| Dec 22, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $123 | 44% |
| Dec 17, 2025 | Guggenheim | maintain | Buy → Buy | $140 | 52% |
| Dec 12, 2025 | Canaccord Genuity | maintain | Buy → Buy | $141 | 48% |
| Dec 12, 2025 | Goldman Sachs | maintain | Buy → Buy | $157 | 54% |
| Dec 12, 2025 | Citizens | maintain | Market Outperform → Market Outperform | $167 | 46% |
| Dec 11, 2025 | Needham | maintain | Buy → Buy | $145 | 50% |
| Nov 25, 2025 | Citigroup | initiate | — → Buy | $136 | 54% |
| Nov 10, 2025 | Canaccord Genuity | maintain | Buy → Buy | $114 | 48% |
| Nov 7, 2025 | Needham | maintain | Buy → Buy | $120 | 50% |
| Nov 4, 2025 | Needham | maintain | Buy → Buy | $122 | 50% |
| Oct 17, 2025 | Goldman Sachs | maintain | Buy → Buy | $139 | 54% |
Price Target Trend
Jun 21, 2026 Latest: $140.53 Oct 25, 2026
EPS Estimates
0q $-0.74
Lo: $-0.85 Hi: $-0.66
13 analysts ▲3
+1q $-0.73
Lo: $-0.93 Hi: $-0.57
13 analysts ▲2
0y $-3.04
Lo: $-3.36 Hi: $-2.82
13 analysts ▲3
+1y $-0.63
Lo: $-2.45 Hi: $0.49
13 analysts ▲2
Cross-Platform Signals
No cross-platform signals in the last 90 days